SCHEMBL10044532

SCHEMBL10044532

Nc1cccc(S(=O)(=O)Nc2nc3ccccc3nc2Cl)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 11/20 0.72
KDM4E B2RXH2 6/20 0.72
NPSR1 Q6W5P4 1/20 0.72
ALDH1A1 P00352 7/20 0.67
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
HPGD P15428 1/20 0.67
POLB P06746 3/20 0.64
L3MBTL1 Q9Y468 2/20 0.61
HTT P42858 1/20 0.61
CDC25A P30304 1/20 0.61
CDC25B P30305 1/20 0.61
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304390 0.86 RXFP1 (0.76) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL3576814 0.85 ALDH1A1 (0.78) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL189044 0.84 RXFP1 (1.00) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL2302090 0.84 RXFP1 (0.72) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL2302089 0.84 RXFP1 (0.73) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL16154583 0.82 RXFP1 (0.68) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL15180084 0.81 RXFP1 (0.67) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL4346612 0.80 CDC25A (0.52) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL189621 0.80 MEN1 (0.66) RXFP1KDM4ENPSR1ALDH1A1MEN1
SCHEMBL15721518 0.79 MEN1 (0.64) RXFP1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012052420-A1 METHOD FOR PREPARING SUBSTITUTED N-(3-AMINO-QUINOXALIN-2-YL)-SULFONAMIDES AND THEIR INTERMEDIATES N-(3-CHLORO-QUINOXALIN-2-YL)SULFONAMIDES MERCK SERONO S.A. GENEVA (CH) 2012-04-26 WO disclosed